Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: A novel hypothesis of early gastric carcinogenesis based on mucin phenotype

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Sugai, Tamotsu ^a   Tsukahara, Mitsunori ^a   Endoh, Masaki ^a   Shioi, Yoshihiro ^a   Takebe, Noriko ^a   Mue, Yoshiharu ^a   Matsushita, Hiroo ^b   Toyota, Minoru ^c   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Health Insurance Hitoyoshi General Hospital   (Japan)

^c SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN A; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6; PROTEIN P21; PROTEIN P27; PROTEIN P53; CELL CYCLE PROTEIN; CYCLINE; P27 ANTIGEN; STOMACH MUCIN;

ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PHENOTYPE; STOMACH CANCER; STOMACH CARCINOGENESIS; TISSUE DIFFERENTIATION; ADENOCARCINOMA; CELL DIFFERENTIATION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN A; GASTRIC MUCINS; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; PHENOTYPE; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954637912     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-55     Document Type: Article

References (34)

1. Ioachim E. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Int J Clin Pract 2008, 62:1736-1743. 10.1111/j.1742-1241.2006.01105.x, 19143860.
2. Tanaka H, Fujii Y, Hirabayashi H, Miyoshi S, Sakaguchi M, Yoon HE, Matsuda H. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int J Cancer 1998, 79:111-115. 10.1002/(SICI)1097-0215(19980417)79:2<111::AID-IJC2>3.0.CO;2-W, 9583722.
3. Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T. Expression of cell cycle markers in colorectal carcinoma superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 1999, 84:225-233. 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.0.CO;2-A, 10371338.
4. Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstädter C, Quintanilla-Martinez L, Busch R, Höfler H, Fend F, Luber B. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol 2007, 60:756-761. 10.1136/jcp.2006.038976, 17483253.
5. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, Thomas V, Ganguly SS, Grant C. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 2005, 91:243-252. 10.1002/jso.20324, 16121348.
6. Liu XP, Kawauchi S, Oga A, Suehiro Y, Tsushimi K, Tsushimi M, Sasaki K. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology 2001, 39:603-610. 10.1046/j.1365-2559.2001.01283.x, 11903579.
7. Han S, Kim HY, Park K, Lee MS, Kim HJ, Kim YD. Expression of p27Kip1 and cyclin D1 proteins is inversely correlated and is associated with poor clinical outcome in human gastric cancer. J Surg Oncol 1999, 71:147-154. 10.1002/(SICI)1096-9098(199907)71:3<147::AID-JSO3>3.0.CO;2-5, 10404130.
8. Li JQ, Miki H, Wu F, Saoo K, Nishioka M, Ohmori M, Imaida K. Cyclin A correlates with carcinogenesis and metastasis, and p27 (kip1) correlates with lymphatic invasion, in colorectal neoplasms. Hum Pathol 2002, 33:1006-1015. 10.1053/hupa.2002.125774, 12395374.
9. Mrena J, Wiksten JP, Kokkola A, Nordling S, Haglund C, Ristimäki A. Prognostic significance of cyclin A in gastric cancer. Int J Cancer 2006, 119:1897-1901. 10.1002/ijc.21944, 16708383.
10. Bani-Hani KE, Almasri NM, Khader YS, Sheyab FM, Karam HN. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer. Clin Cancer Res 2005, 11:1447-1453. 10.1158/1078-0432.CCR-04-1730, 15746045.
11. Milne AN, Carvalho R, Morsink FM, Musler AR, de Leng WW, Ristimäki A, Offerhaus GJ. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 2006, 19:564-572. 10.1038/modpathol.3800563, 16474375.
12. Sugai T, Nakamura S, Uesugi N, Habano W, Yoshida T, Tazawa H, Orii S, Suto T, Itoh C. Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer. Cytometry 1999, 38:111-117. 10.1002/(SICI)1097-0320(19990615)38:3<111::AID-CYTO4>3.0.CO;2-T, 10397330.
13. Sasaki I, Yao T, Nawata H, Tsuneyoshi M. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 1999, 85:1719-1729. 10.1002/(SICI)1097-0142(19990415)85:8<1719::AID-CNCR11>3.0.CO;2-V, 10223565.
14. Tsukamoto T, Yamamoto M, Ogasawara N, Ushijima T, Nomoto T, Fujita H, Matsushima T, Nozaki K, Cao X, Tatematsu M. beta-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas. Cancer Sci 2003, 94:1046-1051. 10.1111/j.1349-7006.2003.tb01399.x, 14662019.
15. Tsukashita S, Kushima R, Bamba M, Nakamura E, Mukaisho K, Sugihara H, Hattori T. Beta-catenin expression in intramucosal neoplastic lesions of the stomach. Comparative analysis of adenoma/dysplasia, adenocarcinoma and signet-ring cell carcinoma. Oncology 2003, 64:251-258. 10.1159/000069310, 12697966.
16. Sugai T, Inomata M, Uesugi N, Jiao Y-F, Endoh M, Orii S, Nakamura S. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: A proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia. Pathol Int 2004, 54:425-435. 10.1111/j.1440-1827.2004.01643.x, 15144402.
17. Sugai T, Habano W, Uesugi N, Jiao Y-F, Nakamura S, Abe K, Takagane A, Terashima M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers - a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol 2004, 17:1223-1234. 10.1038/modpathol.3800170, 15154009.
18. Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 2000, 157:717-722. 1949419, 10980110.
19. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000, 191:257-263. 10.1002/1096-9896(2000)9999:9999<::AID-PATH631>3.0.CO;2-2, 10878546.
20. Japanese Research Society for Gastric Cancer The General Rules for the Gastric Cancer study. 1993, 64-89. Tokyo: Kanehara-shuppan, 12, Japanese Research Society for Gastric Cancer.
21. Yao T, Tsutsumi S, Akaiwa Y, Takata M, Nishiyama K, Kabashima A, Tsuneyoshi M. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 2001, 92:755-761.
22. King RJ, Coffer AI, Gilbert J, Lewis K, Nash R, Millis R, Raju S, Taylor RW. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res 1985, 45:5728-5733.
23. Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 1997, 18:1139-1148. 10.1093/carcin/18.6.1139, 9214595.
24. Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 1999, 50:401-423. 10.1146/annurev.med.50.1.401, 10073286.
25. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T. p27 expression and gastric carcinoma. Nat Med 1997, 3:593. 10.1038/nm0697-593, 9176477.
26. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 2001, 91:1745-1751. 10.1002/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H, 11335900.
27. Wiech T, Nikolopoulos E, Lassman S, Heidt T, Schöpflin A, Sarbia M, Werner M, Shimizu Y, Sakka E, Ooka T, zur Hausen A. Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer. Virchows Arch 2008, 452:621-627. 10.1007/s00428-008-0594-9, 18437417.
28. Feakins RM, Nickols CD, Bidd H, Walton SJ. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Hum Pathol 2003, 34:1276-1282. 10.1016/j.humpath.2003.07.005, 14691913.
29. Müller W, Noguchi T, Wirtz HC, Hommel G, Gabbert HE. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer. J Pathol 1999, 189:186-193. 10.1002/(SICI)1096-9896(199910)189:2<186::AID-PATH418>3.0.CO;2-L, 10547573.
30. Kouraklis G, Katsoulis IE, Theocharis S, Tsourouflis G, Xipolitas N, Glinavou A, Sioka C, Kostakis A. Does the Expression of Cyclin E, pRb, and p21 Correlate with Prognosis in Gastric Adenocarcinoma?. Dig Dis Sci 2008, (5):1015-20.
31. Pannequin J, Delaunay N, Buchert M, Surrel F, Bourgaux JF, Ryan J, Boireau S, Coelho J, Pélegrin A, Singh P, Shulkes A, Yim M, Baldwin GS, Pignodel C, Lambeau G, Jay P, Joubert D, Hollande F. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors. Gastroenterology 2007, 133:1554-1568. 10.1053/j.gastro.2007.08.023, 17920061.
32. Wong SC, Lo ES, Chan AK, Lee KC, Hsiao WL. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Mol Pathol 2003, 56:347-352. 10.1136/mp.56.6.347, 1187354, 14645698.
33. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, Tokino T, Mori M, Imai K, Shinomura Y. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 2007, 26:4699-4713. 10.1038/sj.onc.1210259, 17297461.
34. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, Mori M, Imai K, Tokino T, Shinomura Y. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 2007, 28:2459-2466. 10.1093/carcin/bgm178, 17675336.